18102-30-2

Basic information

• Product Name: 2amino-6-methylanisole
• Synonyms: 2amino-6-methylanisole;2-Methoxy-3-MethylbenzenaMine
• CAS NO: 18102-30-2
• Molecular Formula: C₈H₁₁NO
• Molecular Weight: 137.17904
• Mol File: 18102-30-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2amino-6-methylanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 2amino-6-methylanisole(18102-30-2)
• EPA Substance Registry System: 2amino-6-methylanisole(18102-30-2)

Safety Data

• Hazardous Substances Data: 18102-30-2(Hazardous Substances Data)

Usage

Uses

2-Methoxy-3-methylaniline is an important building block.

Upstream product

• 18102-29-9 2-methyl-6-nitroanisole 
• 7647-01-0 hydrogenchloride 
• 103095-90-5 1-(2-methoxy-3-methyl-phenyl)-ethanone oxime 
• 578-58-5 2-methylmethoxybenzene 
• 13073-29-5 2-methyl-6-nitrophenol 

Downstream Products

• 18102-31-3 2-methoxy-3-methylphenol 
• 2207-57-0 2-methoxy-3-methyl-1,4-benzoquinone 
• 1760-80-1 2-methoxy-3-methylbenzene-1,4-diol 
• 143359-98-2 acetic acid-(2-methoxy-3-methyl-anilide) 
• 25674-52-6 2-methoxy-3-mercapto-toluene 
• 5460-31-1 3-nitro-o-cresol 
• 50741-92-9 2-methyl-4-nitroanisole 
• 4837-88-1 6-methoxy-2-nitrotoluene 
• 861609-40-7 2-methoxy-3-methyl-4-nitro-aniline 
• 861609-39-4 2-methoxy-3-methyl-5-nitro-aniline 
• 861548-37-0 acetic acid-(2-methoxy-3-methyl-4-nitro-anilide) 
• 861613-25-4 acetic acid-(2-methoxy-3-methyl-6-nitro-anilide) 
• 861613-27-6 acetic acid-(2-methoxy-3-methyl-5-nitro-anilide) 

Relevant articles and documents

Total synthesis of the isoquinolinium metabolite ETM-204 of Trabectidin

Ecteinascidin-743 (Trabectidin, Trabectedin, Yondelis) is a synthetically obtained pharmaceutical drug originally isolated from a marine tunicate. Trabectedin is used for the chemotherapy of soft-tissue sarcoma and ovarian cancer. Th

Copper-Catalyzed Domino [1,3]/[1,2] Rearrangement for the Efficient Synthesis of Multisubstituted ortho-Anisidines

Multisubstituted ortho-anisidines were efficiently synthesized via cationic N-heterocyclic carbene-Cu-catalyzed domino rearrangement of N-methoxyanilines that possess an electron-donating functional group, such as an alkyl or an aryl group, at the ortho position. The reaction proceeded first through a [1,3]-rearrangement of the methoxy group to the ortho position bound to the electron-donating substituent, followed by a semipinacol type [1,2]-rearrangement of the electron-donating group from the ortho to the meta position. Mechanistic studies suggest that both rearrangement reactions are promoted by a cationic Cu catalyst.

COUMARIN DERIVATIVES AND METHODS OF USE IN TREATING CYSTIC FIBROSIS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND MISFOLDED PROTEIN DISORDERS

Novel CFTR corrector compounds that are effective in rescuing halide efflux, delF508-CFTR protein processing, and apical functional chloride ion transport in a cell are provided. Also provided are methods for treating protein folding disorders (e.g., cyst

COUMARIN DERIVATIVES AND METHODS OF USE IN TREATING HYPERPROLIFERATIVE DISEASES

Coumarin derivative compounds and methods for the treatment of hyperproliferative diseases, such as cancer, polycystic kidney disease, and fibrosis of different tissues (e.g., idiopathic pulmonary fibrosis), are provided. The methods include administering

Amination of arenes with N,N-dimethyl-2-imidazolidinone O-methoxyacetyloxime

Treatment of nucleophilic arenes with N,N-dimethyl-2imidazolidinone O-methoxyacetyloxime and SnCl4 produced the corresponding N-arylimines, which were converted to anilines by hydrolysis with CsOH and to N-methylanilines by LiAlH4 reduction.